INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,030 | +5686.4% | 648,879 | +6548.4% | 0.06% | +2850.0% |
| Q2 2023 | $398 | +9.3% | 9,760 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $364 | +6.7% | 9,760 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $341 | -99.9% | 9,760 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $546,000 | +8.1% | 9,760 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $505,000 | -28.8% | 9,760 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $709,000 | -38.7% | 9,760 | -0.2% | 0.00% | -40.0% |
| Q4 2021 | $1,156,000 | -11.9% | 9,779 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $1,312,000 | -17.1% | 9,779 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $1,583,000 | +101.7% | 9,779 | 0.0% | 0.01% | +75.0% |
| Q1 2021 | $785,000 | +47.6% | 9,779 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $532,000 | – | 9,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |